Highlights from the 58th meeting of the American Society of Haematology, 1-6 December 2016, San Diego, USA

Research output: Contribution to journalArticlepeer-review

Abstract

The recent 58th Annual American Society of Haematology (ASH) meeting held in San Diego shed light on the usual mixture of groundbreaking basic and translational science and the recent practice-changing clinical trials. Recurrent themes this year were the use of recent next-generation sequencing (NGS) techniques to perfect prognostic stratification and disease monitoring. Newer prospects on the role of metabolism in normal and malignant haemopoiesis and mature data on long-awaited trials on immunotherapy and CAR-T cells in lymphoid neoplasms were also discussed.

Original languageEnglish
Article number725
Journalecancermedicalscience
Volume11
DOIs
Publication statusPublished - Mar 9 2017

Keywords

  • CAR T cell
  • Clinical trial
  • Leukaemia
  • Lymphoma
  • Minimal residual disease
  • Sequencing

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Highlights from the 58th meeting of the American Society of Haematology, 1-6 December 2016, San Diego, USA'. Together they form a unique fingerprint.

Cite this